Aphasia, Primary Progressive
8
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech
Propranolol in Primary Progressive Aphasia
Effects of Transcranial Direct Current Stimulation (tDCS) on Inhibition and Brain Function in Primary Progressive Aphasia
Dopaminergic Therapy for Frontotemporal Dementia Patients
Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia
Spaced Retrieval as Treatment for Aphasia
rTMS for the Treatment of Primary Progressive Aphasia: A Randomized Controlled Trial
Characterisation of Primary Progressives Aphasias